170 related articles for article (PubMed ID: 10805422)
1. Millennium Memorabilia Issue on Apheresis: part 2. Centrifugal devices, adsorbents, leukocyte filters, and extracorporeal immunomodulations.
Murabayashi S
Ther Apher; 2000 Apr; 4(2):71-2. PubMed ID: 10805422
[No Abstract] [Full Text] [Related]
2. Current devices and new trends in theraputic apheresis.
Murabayashi S
Ther Apher Dial; 2003 Feb; 7(1):36. PubMed ID: 12921112
[No Abstract] [Full Text] [Related]
3. [Future and limits of immunohemotherapy. Great possibilities with apheresis].
Norda R; Lundkvist I; Söderström T
Lakartidningen; 1995 Jan; 92(3):155-60. PubMed ID: 7837849
[No Abstract] [Full Text] [Related]
4. Beyond dialysis: current and emerging blood purification techniques.
Stegmayr B; Ramlow W; Balogun RA
Semin Dial; 2012; 25(2):207-13. PubMed ID: 22428812
[TBL] [Abstract][Full Text] [Related]
5. The lipid- and lipoprotein- [LDL-Lp(a)] apheresis techniques. Updating.
Stefanutti C; Morozzi C; Perrone G; Di Giacomo S; Vivenzio A; D'Alessandri G
G Chir; 2012; 33(11-12):444-9. PubMed ID: 23140934
[TBL] [Abstract][Full Text] [Related]
6. Future trends in apheresis.
Freireich EJ
Prog Clin Biol Res; 1981; 65():155-62. PubMed ID: 7330070
[No Abstract] [Full Text] [Related]
7. [Immunomodulation with apheresis technics].
Liebert A; Quietzsch D; Zimmermann S
Allerg Immunol (Leipz); 1986; 32(1):5-18. PubMed ID: 2940851
[TBL] [Abstract][Full Text] [Related]
8. Adsorbent: a determinant for the future development of therapeutic apheresis.
Akizawa T
Ther Apher; 1998 Feb; 2(1):1-2. PubMed ID: 10227781
[No Abstract] [Full Text] [Related]
9. [Organizational aspects of extracorporeal blood correction service].
Kruglov EE; Onoprienko GA; Shumskiĭ VI; Avash IuB; Solodkiĭ VA; Vatazin AV; Fomin AM
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2002; (5):50-1. PubMed ID: 12494580
[No Abstract] [Full Text] [Related]
10. [Review. The status of plasmapheresis and apheresis].
Schmitt E; Klinkmann H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(3):291-309. PubMed ID: 2428704
[TBL] [Abstract][Full Text] [Related]
11. Quo vadis haemapheresis. Current developments in haemapheresis.
Borberg H
Transfus Apher Sci; 2006 Feb; 34(1):51-73. PubMed ID: 16412691
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic apheresis for nephrologists: an introduction.
Balogun RA
Semin Dial; 2012; 25(2):113. PubMed ID: 22428810
[No Abstract] [Full Text] [Related]
13. Available removal systems: state of the art.
Sawada K; Malchesky PS; Nosé Y
Curr Stud Hematol Blood Transfus; 1990; (57):51-113. PubMed ID: 2272207
[No Abstract] [Full Text] [Related]
14. Spin doctors: new innovations for centrifugal apheresis.
Kambic HE; Nosé Y
Ther Apher; 1997 Aug; 1(3):284-305. PubMed ID: 10225752
[TBL] [Abstract][Full Text] [Related]
15. Advances in apheresis therapy for glomerular diseases.
Yokoyama H; Wada T; Zhang W; Yamaya H; Asaka M
Clin Exp Nephrol; 2007 Jun; 11(2):122-127. PubMed ID: 17593511
[TBL] [Abstract][Full Text] [Related]
16. Lymphocytapheresis.
Takenaka Y
Artif Organs; 1996 Aug; 20(8):914-6. PubMed ID: 8853806
[TBL] [Abstract][Full Text] [Related]
17. Correction of hyperviscosity by apheresis.
Zarkovic M; Kwaan HC
Semin Thromb Hemost; 2003 Oct; 29(5):535-42. PubMed ID: 14631553
[TBL] [Abstract][Full Text] [Related]
18. [Methods of plasmapheresis using blood fractionation devices].
Kalinin NN
Sov Med; 1989; (8):40-5. PubMed ID: 2683140
[No Abstract] [Full Text] [Related]
19. Low density lipoprotein (LDL) apheresis is currently recognized as a reliable tool for removal of LDL cholesterol directly from blood in patients with severe hypercholesterolemia.
Agishi T
Artif Organs; 2000 Feb; 24(2):165-6. PubMed ID: 10718772
[No Abstract] [Full Text] [Related]
20. The future in apheresis: the cell revisited.
Hamblin T
Prog Clin Biol Res; 1990; 337():xlv-xlvii. PubMed ID: 1972282
[No Abstract] [Full Text] [Related]
[Next] [New Search]
